Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ ANLEIHEN-Woche #KW34 – 2025: Energiekontor, JDC, The Platform Group, Aream, LEEF, Dt. Rohstoff,... (Anleihen-Finder) +++ PLATFORM GROUP Aktie +4,84%

News zum Sektor Gesundheit aus Finnland

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 100 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1576 Aktien zum Sektor Gesundheit bekannt.
 
20.08.25 - 08:03
337,000 Orion Corporation A shares converted into B shares (GlobeNewswire EN)
 
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 20 AUGUST 2025 at 9.00 EEST        ...
19.08.25 - 08:30
Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results (Accesswire)
 
Faron Pharmaceuticals will publish its half-year financial results for January-June 2025 on Wednesday 27 August 2025 TURKU, FI / ACCESS Newswire / August 19, 2025 / Faron Pharmaceuticals Ltd. (AIM:......
18.08.25 - 17:24
Faron secures FDA pathway for lead cancer therapy (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
18.08.25 - 09:48
Faron wins FDA support to advance bexmarilimab into pivotal trial (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
18.08.25 - 08:30
Faron Pharmaceuticals: Inside Information: Faron to Advance Bexmarilimab into a Registrational Phase 2/3 Study in Treatment-Naïve HR-MDS after Positive Meeting with the FDA (Accesswire)
 
Inside Information: Accelerated approval pathway confirmed for frontline patients with CR + CReq, and Overall Survival as primary endpoints TURKU, FI / ACCESS Newswire / August 18, 2025 / Faron Pha......
18.08.25 - 07:01
Pihlajalinna Plc′s financial reporting and Annual General Meeting in 2026 (Cision)
 
Pihlajalinna Plc         Stock Exchange Release      18 August 2025 at 8:00 a.m. EET Pihlajalinna Plc's financial reporting and Annual General Meeting in 2026 Pihlajalinna will publish its financial information in 2026 as follows: · Financial statements bulletin 2025: 12 February 2026 · Annual Report 2025: no later than week 11 · Interim Report January–March 2026: 28 April 2026 · Half Year Financial Report January–June 2026: 23 July 2026 · Interim Report January–September 2026: 28 October 2026 The Annual General Meeting is planned to be held on Tuesday 31 March...
14.08.25 - 07:24
Bioretec Ltd′s Half-year report 2025: Strong support for future growth from a successful rights issue (PR Newswire)
 
TAMPERE, Finland, Aug. 14, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 14 August 2025 at 8.00 am EEST This company announcement is a summary of Bioretec Ltd's half-year report for January–June 2025. The complete half-year report with tables is attached to this release as a pdf......
13.08.25 - 10:12
Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries (PR Newswire)
 
OSLO, Norway, Aug. 13, 2025 /PRNewswire/ -- Navamedic is pleased to announce that it has received final approval for the packaging material in national languages for Norway, Sweden and Denmark, following the earlier announcement on June 27th. Orion Corporation ("Orion"), the product......
13.08.25 - 09:54
Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries. (Cision)
 
Oslo, Norway – 2025.08.13 – Navamedic is pleased to announce that it has received final approval for the packaging material in national languages for Norway, Sweden and Denmark, following the earlier announcement on June 27th. Orion Corporation (“Orion”), the product licensor for Finland and the rest of the EU, has also obtained final confirmation for the Finnish market. "We are excited to have received the last approvals, paving the way for our go-to-market launch in the Nordic region," said Kathrine Gamborg Andreassen, Chief Executive Officer of Navamedic. Flexilev® in OraFID® ensures...
13.08.25 - 08:01
Laura Karotie appointed Senior Vice President, Corporate Health, and member of Terveystalo′s Executive Team (Cision)
 
Terveystalo Plc, Stock Exchange Release 13 August 2025 at 9:00 a.m. EEST Laura Karotie, b. 1979, M.Sc. (Eng.), has been appointed SVP, Corporate Health at Terveystalo and a member of the Group Executive Team as of 1 October 2025. Laura Karotie will report to Ville Iho, President and CEO. Laura Karotie joins Terveystalo from Caverion, a real estate and industrial services company, where she has held multiple leadership roles. Most recently, she served as Vice President of Advisory & Partnerships at Caverion Finland and was a member of the Management Team. Prior to her tenure at...
10.08.25 - 11:48
Proactive health highlights: GSK, Novo, Futura, Faron, Immupharma, Creo and more (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
08.08.25 - 16:30
Faron Pharmaceuticals Ltd: Holding(s) in Company (Accesswire)
 
TURKU, FI / ACCESS Newswire / August 8, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN)Faron Pharmaceuticals Ltd | Company announcement | August 08, 2025 at 17:00:00 EESTTR-1: Standard form for ......
08.08.25 - 14:30
Optomed Plc - Managers′ transactions - Tauriainen (Cision)
 
Optomed Plc    Stock Exchange Release    8 August 2025 at 15.30, Helsinki   Optomed Plc - Managers' transactions - Tauriainen ____________________________________________ Person subject to the notification requirement Name: Tauriainen, Reijo Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250808112311_65 ____________________________________________ Transaction date: 2025-08-08 Venue not applicable Instrument type: SHARE ISIN:...
08.08.25 - 14:30
Optomed Plc - Managers′ transactions - Salonen (Cision)
 
Optomed Plc    Stock Exchange Release    8 August 2025 at 15.30, Helsinki   Optomed Plc - Managers' transactions - Salonen ____________________________________________ Person subject to the notification requirement Name: Salonen, Petri Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250808112311_64 ____________________________________________ Transaction date: 2025-08-08 Venue not applicable Instrument type: SHARE ISIN:...
08.08.25 - 14:30
Optomed Plc - Managers′ transactions - Badlani (Cision)
 
Optomed Plc    Stock Exchange Release    8 August 2025 at 15.30, Helsinki   Optomed Plc - Managers' transactions - Badlani ____________________________________________ Person subject to the notification requirement Name: Badlani, Sameer Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250808112311_60 ____________________________________________ Transaction date: 2025-08-08 Venue not applicable Instrument type: SHARE ISIN:...
08.08.25 - 14:30
Optomed Plc - Managers′ transactions - Calarco (Cision)
 
Optomed Plc    Stock Exchange Release    8 August 2025 at 15.30, Helsinki   Optomed Plc - Managers' transactions - Calarco ____________________________________________ Person subject to the notification requirement Name: Calarco, Catherine Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250808112311_61 ____________________________________________ Transaction date: 2025-08-08 Venue not applicable Instrument type: SHARE ISIN:...
08.08.25 - 14:30
Optomed Plc - Managers′ transactions - Wen (Cision)
 
Optomed Plc    Stock Exchange Release    8 August 2025 at 15.30, Helsinki   Optomed Plc - Managers' transactions - Wen ____________________________________________ Person subject to the notification requirement Name: Wen, Leana Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250808112311_66 ____________________________________________ Transaction date: 2025-08-08 Venue not applicable Instrument type: SHARE ISIN: FI4000410881...
08.08.25 - 14:30
Optomed Plc - Managers′ transactions - Mäkinen (Cision)
 
Optomed Plc    Stock Exchange Release    8 August 2025 at 15.30, Helsinki   Optomed Plc - Managers' transactions - Mäkinen ____________________________________________ Person subject to the notification requirement Name: Mäkinen, Seppo Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250808112311_63 ____________________________________________ Transaction date: 2025-08-08 Venue not applicable Instrument type: SHARE ISIN:...
08.08.25 - 14:30
Optomed Plc - Managers′ transactions - Lee (Cision)
 
Optomed Plc        Stock Exchange Release    8 August 2025 at 15.30, Helsinki Optomed Plc - Managers' transactions - Lee ____________________________________________ Person subject to the notification requirement Name: Lee, Ty Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250808112311_62 ____________________________________________ Transaction date: 2025-08-08 Venue not applicable Instrument type: SHARE ISIN: FI4000410881...
08.08.25 - 14:30
Change in Optomed′s holding of treasury shares (Cision)
 
Optomed Plc Stock Exchange Release 8 August 2025 at 15.30, Helsinki Change in Optomed's holding of treasury shares Optomed has conveyed 12,687 treasury shares to the members of the Board of Directors as a part of the Board members' annual remuneration in accordance with the decision of the Annual General Meeting 2025. The amount of shares is based on the monthly remuneration decided by the Annual General Meeting and Optomed's value weighted average share price between 31 July and 6 August 2025.   The total amount of treasury shares is now 22,042. Optomed Plc Further enquiries...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das nackte Kind, das zagt nicht; mit seinem Pfennig springt es fort und kennt recht gut den Sammelort - ich meine des Bäckers Laden. - Johann Wolfgang von Goethe
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!